Archives

img-01

Japan Pharmaceutical Update

Recent deregulation reforms within the Japanese pharmaceutical market have been applauded by international pharmaceutical companies and associations alike. Major reform efforts include: withdrawal of the reference pricing system, speeding up the approval process for new drugs, more acceptance of foreign clinical data,... Read More

img-01

Japan Medical Regulatory Update

This article contains a series of news briefs and updates with regard to Japan's medical device and pharmaceutical markets. Topics include: hospital roles in billing, reimbursing, and controlling medical equipment; pharmaceutical deregulation; liberalized procurement policy for medical products; and drug pricing policy. Read More

img-01

Product Registration in Taiwan

As of 1995, U.S. medical manufacturers held about 40% of Taiwan’s import market and that number will continue increase as Taiwan expands its medical technology market. Currently, the Department of Health (DOH) oversees all national health policies, formulates new programs, and manages... Read More